Gemina Labs Establishes UK Subsidiary And Appoints David Browning As Head Of Productization
VANCOUVER, BC / ACCESSWIRE / February 23, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to...
Month: February 2022
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device
Announcement follows FDA clearancePre-Orders begin on February 23, 2022 with units shipping April 1, 2022REDWOOD CITY, CA / ACCESSWIRE /...
Coborn’s, Inc. and Bonum Health(TM) (A TRxADE HEALTH Company) Ink Telemedicine Deal To Deploy Deeply Discounted Telemedicine to Uninsured and Under-Insured Consumers
TAMPA, FL / ACCESSWIRE / February 23, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, healthcare platform...
Cloud DX and Medtronic Sign First Contract with Ontario Hospital
Healthcare collaboration's first Remote Patient Monitoring deployment with St. Mary's General Hospital for Virtual COPD (Chronic Obstructive Pulmonary Disease) programNews...
NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021
Recent Highlights:Full year 2021 consolidated revenue increased 9% year-over-year; excluding COVID-19 PCR testing revenue, consolidated revenue increased 16%Fourth quarter consolidated...
NeonMind Appoints Emergency and Addiction Expert Dr. Dinesh Bhayana, as Site Medical Director of its Inaugural Specialty Mental Health Clinic
VANCOUVER, BC / ACCESSWIRE / February 23, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug...
Omada Health Closes $192 Million Series E Financing to Bring Virtual-First Care to Millions
Fidelity leads round to help Omada deliver on its mission to improve health outcomes for people living with chronic conditionsStrategic...
Lumos Pharma to Report Full Year 2021 Financial Results and Host Conference Call on March 10, 2022
AUSTIN, Texas, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for...
INmune Bio, Inc. to Report Fourth Quarter 2021 Financial Results and Provide a Corporate Update on Thursday, March 3
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, Feb. 23, 2022...
Lowell Farms Takes the Lead as California’s Largest Seller of Packaged Cannabis Flower Per Headset
Award-winning California cannabis company tops more than 500 statewide competitors in sales, led by premier flower brands Lowell Herb and...
PacBio Welcomes Dr. Michael Eberle as Vice President of Computational Biology
Genomics Industry Veteran to Oversee Development of Robust Computational Biology ProgramMENLO PARK, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- PacBio...
Intercept to Announce Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization...
Ensysce Biosciences Announces Participation in the 34th Annual Roth Conference
SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a...
Stryker completes acquisition of Vocera Communications
Kalamazoo, MI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the previously announced...
ChemoCentryx to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on Tuesday, March 1, 2022
MOUNTAIN VIEW, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's fourth quarter...
AREV Life Sciences Completes Lab and Fungi Fruiting Room Build
VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- via InvestorWire - AREV Life Sciences Global Corp. (CSE: AREV) (OTC:...
Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO today announced they have reached...
Entrada Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
BOSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives...
Jounce Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Wednesday, March 2, 2022
CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
Rhythm Pharmaceuticals Announces Promotions within its Executive Leadership Team
BOSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the...